Known targets — ChEMBL curated mechanism
ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO
The experimentally established mechanism targets of Tetrylammonium. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.90 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.90 |
| ▸ | ATM | Q13315 | 1/20 | 0.90 |
| ▸ | TSHR | P16473 | 2/20 | 0.80 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.80 |
| ▸ | KCNA1 | Q09470 | 1/20 | 0.80 |
| ▸ | DNM1 | Q05193 | 4/20 | 0.37 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tetrylammonium SCHEMBL27437383 | 0.95 | KDM4E (0.82) | KDM4EPMP22ATMTSHRNFKB1 | |
| Tetrylammonium SCHEMBL352577 | 0.95 | KDM4E (0.82) | KDM4EPMP22ATMTSHRNFKB1 | |
| Tetrylammonium SCHEMBL5374883 | 0.95 | KDM4E (1.00) | KDM4EPMP22ATMTSHRNFKB1 | |
| Tetrylammonium SCHEMBL5142182 | 0.95 | TSHR (0.89) | KDM4EPMP22ATMTSHRNFKB1 | |
| Tetrylammonium SCHEMBL616647 | 0.95 | TSHR (0.89) | KDM4EPMP22ATMTSHRNFKB1 | |
| Tetrylammonium SCHEMBL1035999 | 0.95 | TSHR (0.89) | KDM4EPMP22ATMTSHRNFKB1 | |
| Tetrylammonium SCHEMBL10982449 | 0.95 | KDM4E (1.00) | KDM4EPMP22ATMTSHRNFKB1 | |
| Tetrylammonium SCHEMBL3722218 | 0.95 | TSHR (0.89) | KDM4EPMP22ATMTSHRNFKB1 | |
| Tetrylammonium SCHEMBL49847 | 0.95 | KDM4E (1.00) | KDM4EPMP22ATMTSHRNFKB1 | |
| Tetrylammonium SCHEMBL8341373 | 0.90 | TSHR (0.80) | KDM4EPMP22ATMTSHRNFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 430 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250177885-A1 | COMPOSITION, SYSTEM AND METHOD FOR REMOVAL OF DETERGENTS FROM AQUEOUS SOLUTIONS | DNA GENOTEK INC. (CA) | 2025-06-05 | — | — | US | claimed |
| US-12214299-B2 | Composition, system and method for removal of detergents from aqueous solutions | DNA GENOTEK INC. (CA) | 2025-02-04 | — | — | US | claimed |
| CN-118767993-A | Process for deactivation of olefin oligomerization catalysts | 沙特基础工业全球技术有限公司 | 2024-10-15 | — | — | CN | claimed |
| EP-3350143-B1 | PROCESS FOR DEACTIVATION OF AN OLEFIN OLIGOMERIZATION CATALYST | SABIC GLOBAL TECHNOLOGIES BV (NL) | 2024-05-15 | — | — | EP | claimed |
| US-20200316493-A1 | A COMPOSITION, SYSTEM AND METHOD FOR REMOVAL OF DETERGENTS FROM AQUEOUS SOLUTIONS | DNA GENOTEK INC. (CA) | 2020-10-08 | — | — | US | claimed |
| US-10407359-B2 | Process for deactivation of an olefin oligomerization catalyst | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2019-09-10 | — | — | US | claimed |
| EP-3464589-A1 | A COMPOSITION, SYSTEM AND METHOD FOR REMOVAL OF DETERGENTS FROM AQUEOUS SOLUTIONS | DNA Genotek Inc. (CA) | 2019-04-10 | — | — | EP | claimed |
| EP-3433010-A1 | METHOD FOR PROCESSING AN OLIGOMERIZATION PRODUCT STREAM | SABIC Global Technologies B.V. (NL) | 2019-01-30 | — | — | EP | claimed |
| US-20180258009-A1 | PROCESS FOR DEACTIVATION OF AN OLEFIN OLIGOMERIZATION CATALYST | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2018-09-13 | — | — | US | claimed |
| EP-3350143-A1 | PROCESS FOR DEACTIVATION OF AN OLEFIN OLIGOMERIZATION CATALYST | SABIC Global Technologies B.V. (NL) | 2018-07-25 | — | — | EP | claimed |
| US-9018431-B2 | Catalyst composition and process for oligomerization of ethylene | SAUDI BASIC INDUSTRIES CORPORATION (SA) | 2015-04-28 | — | — | US | claimed |
| US-20120029258-A1 | Catalyst Composition and Process for Oligomerization of Ethylene | SAUDI BASIC INDUSTRIES CORPORATION (SA) | 2012-02-02 | — | — | US | claimed |
| EP-2239056-B1 | Catalyst composition and process for oligomerization of ethylene | SAUDI BASIC IND CORP (SA) | 2011-07-20 | — | — | EP | claimed |
| WO-2010115520-A1 | CATALYST COMPOSITION AND PROCESS FOR OLIGOMERIZATION OF ETHYLENE | LINDE AG (DE) | 2010-10-14 | — | — | WO | claimed |
| EP-2239056-A1 | Catalyst composition and process for oligomerization of ethylene | Saudi Basic Industries Corporation (SA) | 2010-10-13 | — | — | EP | claimed |
| US-6344563-B1 | SULFIDING, DEHYDROHALOGENATION, FORMATION OF BOND BETWEEN CARBON AND NITROGEN | NORRIS TIMOTHY (US) | 2002-02-05 | — | — | US | claimed |
| CN-1291609-A | Method of preparing 5-lipoxidase inhibitor possessing different heterocyclic ring system | PFIZER PROD INC (US) | 2001-04-18 | — | — | CN | claimed |
| EP-1081146-A1 | Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems | Pfizer Products Inc. (US) | 2001-03-07 | — | — | EP | claimed |
| EP-1081144-A2 | Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems | Pfizer Products Inc. (US) | 2001-03-07 | — | — | EP | claimed |
| US-6136972-A | Preparation of a mannich base intermediate for 2-[(4-heterocyclic-phenoxymethyl)-phenoxy]-alkanoates | FMC CORPORATION (US) | 2000-10-24 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180258009-A1 | PROCESS FOR DEACTIVATION OF AN OLEFIN OLIGOMERIZATION CATALYST | ADH1A, ADH1C, MAX | KDM4E 4509/4885PMP22 3583/4885ATM 1253/4885 |
| US-10407359-B2 | Process for deactivation of an olefin oligomerization catalyst | ADH1A, ADH1C, MAX | KDM4E 4509/4885PMP22 3583/4885ATM 1253/4885 |
| US-20120029258-A1 | Catalyst Composition and Process for Oligomerization of Ethylene | TRRAP, CECR2, C1R | KDM4E 2898/4885PMP22 2444/4885ATM 1279/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.